Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Wearable devices track gout flaresNature reviews. Rheumatology, 2020-10, Vol.16 (10), p.538-538 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/s41584-020-0497-y ;PMID: 32843738Full text available |
|
2 |
Material Type: Article
|
093 The role of US in an atypical presentation of goutRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.317Full text available |
|
3 |
Material Type: Article
|
095 Rasburicase in gout complicated by methaemoglobinaemiaRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.319Full text available |
|
4 |
Material Type: Article
|
i147 Does gout's historical legacy detriment patients in the 21st century?Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.147Full text available |
|
5 |
Material Type: Article
|
023 Managing erosive tophaceous gout in a young patientRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.247Full text available |
|
6 |
Material Type: Article
|
O04 Return of the king: rising incidence of gout in England 2006-2017 (Young investigator award winner 2018)Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.186Full text available |
|
7 |
Material Type: Article
|
Tophaceous Gout and Martel's Sign: Manifestations of advanced goutAPIK Journal of Internal Medicine, 2022-10, Vol.10 (4), p.278-279 [Peer Reviewed Journal]COPYRIGHT 2022 Medknow Publications and Media Pvt. Ltd. ;ISSN: 2666-1802 ;EISSN: 2666-1802 ;EISSN: 2666-1810 ;DOI: 10.4103/ajim.ajim_107_21Full text available |
|
8 |
Material Type: Article
|
Co-morbidities in Patients Presenting with Gout at Tertiary Care Hospital Peshawar, A Cross Sectional Study, 2021 PakistanPakistan journal of medical research, 2022-12, Vol.61 (4), p.150 [Peer Reviewed Journal]COPYRIGHT 2022 Knowledge Bylanes ;ISSN: 0030-9842Full text available |
|
9 |
Material Type: Article
|
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of goutAnnals of the rheumatic diseases, 2020-01, Vol.79 (1), p.31-38 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215315 ;PMID: 31167758Full text available |
|
10 |
Material Type: Article
|
Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trialsBMC cardiovascular disorders, 2018-02, Vol.18 (1), p.24-11, Article 24 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1471-2261 ;EISSN: 1471-2261 ;DOI: 10.1186/s12872-018-0757-9 ;PMID: 29415653Full text available |
|
11 |
Material Type: Article
|
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with GoutThe New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974Full text available |
|
12 |
Material Type: Article
|
Mechanism of Action of Colchicine in the Treatment of GoutClinical therapeutics, 2014-10, Vol.36 (10), p.1465-1479 [Peer Reviewed Journal]The Authors ;2014 The Authors ;2015 INIST-CNRS ;Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 2014 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2014.07.017 ;PMID: 25151572Full text available |
|
13 |
Material Type: Article
|
2016 updated EULAR evidence-based recommendations for the management of goutAnnals of the rheumatic diseases, 2017, Vol.76 (1), p.29-42 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209707 ;PMID: 27457514 ;CODEN: ARDIAOFull text available |
|
14 |
Material Type: Article
|
Update on colchicine, 2017Rheumatology (Oxford, England), 2018-01, Vol.57 (suppl_1), p.i4-i11 [Peer Reviewed Journal]The Author 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2018 ;The Author 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/kex453 ;PMID: 29272515Full text available |
|
15 |
Material Type: Article
|
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research prioritiesNature reviews. Rheumatology, 2021-10, Vol.17 (10), p.633-641 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/s41584-021-00657-4 ;PMID: 34331037Full text available |
|
16 |
Material Type: Article
|
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factorsNature reviews. Rheumatology, 2020-07, Vol.16 (7), p.380-390 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/s41584-020-0441-1 ;PMID: 32541923Full text available |
|
17 |
Material Type: Article
|
Inflammation in gout: mechanisms and therapeutic targetsNature reviews. Rheumatology, 2017-11, Vol.13 (11), p.639-647 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2017 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/nrrheum.2017.155 ;PMID: 28959043Full text available |
|
18 |
Material Type: Article
|
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of GoutRheumatology (Oxford, England), 2007-08, Vol.46 (8), p.1372-1374 [Peer Reviewed Journal]The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2007 ;2007 INIST-CNRS ;The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/kem056a ;PMID: 17522099 ;CODEN: BJRHDFFull text available |
|
19 |
Material Type: Article
|
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort studyClinical and experimental rheumatology, 2023-03, Vol.41 (3), p.628-633 [Peer Reviewed Journal]ISSN: 0392-856X ;ISSN: 1593-098X ;EISSN: 1593-098X ;DOI: 10.55563/clinexprheumatol/eh0jcp ;PMID: 35930471Full text available |
|
20 |
Material Type: Article
|
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.811-820 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209213 ;PMID: 27821644 ;CODEN: ARDIAOFull text available |